Brand owners in the pharmaceutical sector are facing a challenge
to find faster ways to launch brand protection measures. This
challenge grows more complicated and time-consuming when pharma
companies are managing brands across multiple jurisdictions.
World Trademark Review recently published an interview with INTA president-elect David Lossignol,
Global Head of Trademarks at Sandoz International GmbH,
where he manages the company's global trademark portfolio.
Corsearch is a partner of Sandoz.
In the WTR interview, Lossignol compares managing
trademarks in the pharmaceutical industry to the consumer goods
sector because of the need "to be first to market" in a
fast-moving business. He told WTR: " ... you
don't always have as much time to test your marks before the
trademark office and third parties during the opposition process,
so you need to undertake robust searches in a shorter timeframe,
and take smart risks."
